APHIOS CORPORATION

Address

3 E GILL ST
WOBURN, MA, 01801-1720

Information

DUNS: 194643722
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Purging Latent HIV Reservoirs through a Combination HIV Therapeutic

    Amount: $463,205.00

    PROJECT SUMMARY We hypothesize that Protein Kinase C PKC agonists such as the non tumorigenic Bryoids combined with HDAC inhibitors HDACi represent a valuable pharmacological approach to purge lat ...

    SBIRPhase I2016Department of Health and Human Services
  2. Development of cGMP Manufacturing Process for CBD

    Amount: $1,484,298.00

    DESCRIPTION provided by applicant Medical marijuana is now approved in states and the District of Columbia for several medical conditions such as cachexia cancer chronic pain epilepsy and oth ...

    SBIRPhase II2015Department of Health and Human Services
  3. Development of SFS Fractionators

    Amount: $224,947.00

    DESCRIPTION (provided by applicant): The screening of a complex mixture of analytes is not always successful in sensitive screens for specific activities. Often, specific activities are masked by inte ...

    SBIRPhase I2014Department of Health and Human Services
  4. Development of cGMP Manufacturing Process for CBD

    Amount: $224,841.00

    DESCRIPTION (provided by applicant): Medical marijuana is now approved in 20 states and the District of Columbia for several medical conditions such as cachexia, cancer, chronic pain, epilepsy and oth ...

    SBIRPhase I2014Department of Health and Human Services
  5. Alzheimer's Disease Therapeutic

    Amount: $2,409,606.00

    DESCRIPTION (provided by applicant): Alzheimer's Disease (AD) is a significant neurological disorder that afflicts more than 4.5 million Americans and more than 10 million people worldwide. The l ...

    SBIRPhase II2011Department of Health and Human Services
  6. TAS:: 75 0896::TAS SBIR PHASE I TOPIC NCCAM 002

    Amount: $94,448.00

    This Phase I, SBIR contract is to conduct a thorough biological and phytochemical analysis of Harpagophytum procumbens. This should result in discovery of new biologically active molecules and/or a mo ...

    SBIRPhase I2011Department of Health and Human Services
  7. SBIR PHASE 1 TOPIC 43

    Amount: $149,440.00

    The contractor will identify methodologies for broad spectrum inactivation of pathogens in red blood cell concentrates(RBCC). RBCCs are the main components of blood used in transfusion medicine, yet c ...

    SBIRPhase I2011Department of Health and Human Services
  8. Alzheimer's Disease Therapeutic

    Amount: $263,690.00

    DESCRIPTION (provided by applicant): Alzheimer's Disease (AD) is a significant neurological disorder that afflicts more than 4.5 million Americans and more than 10 million people worldwide. The lack o ...

    SBIRPhase I2010Department of Health and Human Services
  9. CFI Inactivation of Human Plasma

    Amount: $344,267.00

    DESCRIPTION (provided by applicant): The worldwide AIDS epidemic, the periodic emergence of Ebola and SARS, and the recent outbreaks of potentially pandemic strains of influenza such as H5N1 have high ...

    SBIRPhase I2009Department of Health and Human Services
  10. D9-THC for Marijuana Addiction

    Amount: $109,761.00

    DESCRIPTION (provided by applicant): ?9-tetrahydrocannabinol (?9-THC) has been shown to alleviate marijuana withdrawal symptoms and thus has potential for treating cannabinoid dependence. However, the ...

    SBIRPhase I2008Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government